Pith. Sign in

RECORD

Compressed radiotherapy treatment planning (CompressRTP): A new paradigm for rapid and high-quality treatment planning optimization

Medical Physics · Submitted 1 Oct 2024

abstract compiled · 2026-09-23 · no language-model review

The authors' main claim Our findings demonstrate that this matrix is highly compressible, enabling a compact representation of the optimization problems and allowing them to be solved more efficiently and accurately.

how it is stated · asserted 1.00 read the record →

Comment (0) Read on arXiv ↗
Cite ▾
arXiv ID2410.00756 (version 1)
Pith IDUIL4NS2P, Pith's permanent record of this paper and its review
CitationGourav Jhanwar, Masoud Zarepisheh, Mojtaba Tefagh. "Compressed radiotherapy treatment planning (CompressRTP): A new paradigm for rapid and high-quality treatment planning optimization." arXiv:2410.00756 (2024). https://pith.science/paper/UIL4NS2P
Claim paper

The compiled record

The paper's own sentences, arranged. Each label is drawn from a closed vocabulary; the number beside it is the probability the classifier gave that label. Numbers in the tables are the authors', checked by code. No sentence in this record was written by a model.

Open the compiled record

Compiled by classifier-1.13.0 via TypeSafe API, question bank abstract-p1-20260923, 2026-09-23: 1 request, 8,228 input tokens.

What the abstract itself states, as probabilities: claims first 0.12 · states limitation 0.13 · human participants 0.90 · controlled comparison 0.71 · randomized assignment 0.02 · states quantitative result 0.88 · compares with prior results 0.72 · mentions code or data availability 0.03.

The abstract, sentence by sentence

arXiv listing abstract v1. Results and the main claim are underlined; .

Background: Radiotherapy treatment planning involves solving large-scale optimization problems that are often approximated and solved sub-optimally due to time constraints. Central to these problems is the dose influence matrix which quantifies the radiation dose delivered from each beamlet to each voxel. Our findings demonstrate that this matrix is highly compressible, enabling a compact representation of the optimization problems and allowing them to be solved more efficiently and accurately. Methods: We precompute the primary (S) and scattering (L) dose contributions of the dose influence matrix A separately for photon therapy, expressed as: A = S + L. Our analysis reveals that the singular values of the scattering matrix L exhibit exponential decay, indicating that L is a low-rank matrix. This allows us to compress L into two smaller matrices: L=HW, where r is relatively small (approximately 5 to 10). Since the primary dose matrix S is sparse, this supports the use of the well-established "sparse-plus-low-rank" decomposition technique for the influence matrix A, approximated as: A = S + H * W. We introduce an efficient algorithm for sparse-plus-low-rank matrix decomposition, even without direct access to the scattering matrix. This algorithm is applied to optimize treatment plans for ten lung and ten prostate patients, using both compressed and sparsified versions of matrix A. We then evaluate the dose discrepancy between the optimized and final plans. We also integrate this compression technique with our in-house automated planning system, ECHO, and evaluate the dosimetric quality of the generated plans with and without compression.

background contribution method result interpretation main claim

What the classifier reports for each sentence. The number is the probability it gave the label.
#sentencerolethe authors' own workstates the main conclusionstrength
s0 Background: Radiotherapy treatment planning involves solving large-scale optimization problems that are often approximated and solved sub-optimally due to time constraints. background 1.00 0.04 0.02 asserted 0.97
s1 Central to these problems is the dose influence matrix which quantifies the radiation dose delivered from each beamlet to each voxel. background 1.00 0.06 0.02 asserted 1.00
s2 Our findings demonstrate that this matrix is highly compressible, enabling a compact representation of the optimization problems and allowing them to be solved more efficiently and accurately. result 0.92 0.92 0.86 asserted 1.00
s3 Methods: We precompute the primary (S) and scattering (L) dose contributions of the dose influence matrix A separately for photon therapy, expressed as: A = S + L. method 1.00 0.92 0.03 asserted 0.97
s4 Our analysis reveals that the singular values of the scattering matrix L exhibit exponential decay, indicating that L is a low-rank matrix. result 0.93 0.94 0.07 asserted 0.86
s5 This allows us to compress L into two smaller matrices: L=HW, where r is relatively small (approximately 5 to 10). method 0.76 0.87 0.09 asserted 0.96
s6 Since the primary dose matrix S is sparse, this supports the use of the well-established "sparse-plus-low-rank" decomposition technique for the influence matrix A, approximated as: A = S + H * W. method 0.62 0.56 0.12 hedged possibility 0.67
s7 We introduce an efficient algorithm for sparse-plus-low-rank matrix decomposition, even without direct access to the scattering matrix. contribution 0.51 0.94 0.07 asserted 1.00
s8 This algorithm is applied to optimize treatment plans for ten lung and ten prostate patients, using both compressed and sparsified versions of matrix A. method 0.99 0.96 0.05 asserted 0.97
s9 We then evaluate the dose discrepancy between the optimized and final plans. method 0.97 0.95 0.03 unclear 0.52
s10 We also integrate this compression technique with our in-house automated planning system, ECHO, and evaluate the dosimetric quality of the generated plans with and without compression. method 0.92 0.96 0.07 asserted 0.87

What kind of paper the classifier reports this is: method or tool 1.00 · evidence from simulation or computation 0.88.

What was examined, and what was not

sources read
  • arXiv listing abstract v1
not examined
  • full text
  • figures and tables
  • references and citing sentences
  • relations to other papers
levels run
  • P abstract
not run
  • S sections
  • T body sentences
  • C citations
  • R cross-paper relations

Every quoted sentence on this record is the authors'. Every label is from Pith's closed vocabulary, with the probability shown beside it. Every number in the measurements table is the authors', checked by code. Record as JSON

The paper
Original abstract

Background: Radiotherapy treatment planning involves solving large-scale optimization problems that are often approximated and solved sub-optimally due to time constraints. Central to these problems is the dose influence matrix which quantifies the radiation dose delivered from each beamlet to each voxel. Our findings demonstrate that this matrix is highly compressible, enabling a compact representation of the optimization problems and allowing them to be solved more efficiently and accurately. Methods: We precompute the primary (S) and scattering (L) dose contributions of the dose influence matrix A separately for photon therapy, expressed as: A = S + L. Our analysis reveals that the singular values of the scattering matrix L exhibit exponential decay, indicating that L is a low-rank matrix. This allows us to compress L into two smaller matrices: L=HW, where r is relatively small (approximately 5 to 10). Since the primary dose matrix S is sparse, this supports the use of the well-established "sparse-plus-low-rank" decomposition technique for the influence matrix A, approximated as: A = S + H * W. We introduce an efficient algorithm for sparse-plus-low-rank matrix decomposition, even without direct access to the scattering matrix. This algorithm is applied to optimize treatment plans for ten lung and ten prostate patients, using both compressed and sparsified versions of matrix A. We then evaluate the dose discrepancy between the optimized and final plans. We also integrate this compression technique with our in-house automated planning system, ECHO, and evaluate the dosimetric quality of the generated plans with and without compression.

Human review

Discussion

Know something about this paper? Leave a comment, or highlight any passage above to comment on it.